Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Largeaud, Laëtitia  [Clear All Filters]
2020
Ricard L, Hirsch P, Largeaud L, Deswarte C, Jachiet V, Mohty M, Rivière S, Malard F, Tenon M, de Vassoigne F, et al. Clonal haematopoiesis is increased in early onset in systemic sclerosis. Rheumatology (Oxford). 2020.
2021
Lafage-Pochitaloff M, Gerby B, Baccini V, Largeaud L, Fregona V, Prade N, Juvin P-Y, Jamrog LAudrey, Bories P, Hébrard S, et al. The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11. Blood Adv. 2021.
2022
Duployez N, Largeaud L, Duchmann M, Kim R, Rieunier J, Lambert J, Bidet A, Larcher L, Lemoine J, Delhommeau F, et al. Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study. Blood. 2022.
Canali A, Vergnolle I, Bertoli S, Largeaud L, Nicolau M-L, Rieu J-B, Tavitian S, Huguet F, Picard M, Bories P, et al. Prognostic impact of unsupervised early assessment of bulk and leukemic stem cell measurable residual disease in acute myeloid leukemia. Clin Cancer Res. 2022.
2024
Dussiau C, Comont T, Knosp C, Vergnolle I, Bravetti C, Canali A, Houvert A, Largeaud L, Daveaux C, Zaroili L, et al. Loss of hematopoietic progenitors heterogeneity is an adverse prognostic factor in lower-risk myelodysplastic neoplasms. Leukemia. 2024.
Fregona V, Bayet M, Bouttier M, Largeaud L, Hamelle C, Jamrog LA, Prade N, Lagarde S, Hébrard S, Luquet I, et al. Stem cell-like reprogramming is required for leukemia-initiating activity in B-ALL. J Exp Med. 2024;221(1).